This study investigates advanced solid tumors. Participants will receive an investigational medication to understand its effects on the condition.
The study evaluates the safety and side effects of the investigational medication. It looks at how the medication interacts with the body and its potential impact.
- Who can participate: Adults with advanced solid tumors, such as non-small cell lung cancer, head and neck squamous cell carcinoma, and triple negative breast cancer, may participate. Participants should have a performance status score of 0 or 1.
- Study details: Participants will receive an investigational medication alone or with another drug to assess safety and effects. Some may receive a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand